Enlivex Files Routine 6-K, Includes Press Release
Ticker: ENLV · Form: 6-K · Filed: Mar 26, 2026 · CIK: 0001596812
| Field | Detail |
|---|---|
| Company | Enlivex Ltd. (ENLV) |
| Form Type | 6-K |
| Filed Date | Mar 26, 2026 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $5 million |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: foreign-issuer, press-release, regulatory-filing
TL;DR
**Enlivex just filed a 6-K with a press release, check the details for potential news.**
AI Summary
Enlivex Ltd. filed a 6-K report on March 26, 2026, indicating a routine foreign issuer report. This filing includes a current report and a press release, suggesting the company is providing an update to investors. For shareholders, this matters because 6-K filings often contain important operational or financial news, and reviewing the attached press release (EX-99.1) would be crucial to understand any specific announcements that could impact the stock's value.
Why It Matters
This filing signals that Enlivex Ltd. is providing an update to the market, and the included press release (EX-99.1) likely contains specific news that could influence investor sentiment and stock price.
Risk Assessment
Risk Level: low — A routine 6-K filing itself is not inherently risky, but the content of the attached press release could contain information that changes the risk profile.
Analyst Insight
An investor should immediately review the attached press release (EX-99.1) to understand the specific news being reported by Enlivex Ltd., as this will determine the actual impact on the stock.
Key Numbers
- 2026-03-26 — Filing Date (The date the 6-K report was filed and accepted by the SEC.)
- 2 — Number of Documents (The filing contains two documents: a current report and a press release.)
- 8820 — Size of Current Report (The size in bytes of the main 6-K document (ea028345301-6k_enlivex.htm).)
- 11261 — Size of Press Release (The size in bytes of the attached press release (EX-99.1).)
- 001-36578 — File No. (The SEC file number for Enlivex Ltd.)
Key Players & Entities
- Enlivex Ltd. (company) — the filer of the 6-K report
- 0001596812 (company) — CIK of Enlivex Ltd.
- 0001213900-26-034383 (dollar_amount) — SEC Accession No. for the filing
Forward-Looking Statements
- The press release (EX-99.1) will contain an update on Enlivex Ltd.'s pharmaceutical preparations or clinical trials. (Enlivex Ltd.) — medium confidence, target: 2026-03-26
FAQ
What is the purpose of a 6-K filing for Enlivex Ltd.?
A 6-K filing is a 'Report of foreign issuer' under Rules 13a-16 and 15d-16, used by foreign private issuers like Enlivex Ltd. to report material information to the SEC that is made public in their home country or filed with a foreign stock exchange.
When was this specific 6-K filing by Enlivex Ltd. submitted and accepted?
This 6-K filing by Enlivex Ltd. was filed and accepted on March 26, 2026, at 08:32:01.
What types of documents are included in this 6-K filing?
This 6-K filing includes two documents: a 'CURRENT REPORT' (ea028345301-6k_enlivex.htm) and a 'PRESS RELEASE' (ea028345301ex99-1_enlivex.htm).
What is Enlivex Ltd.'s CIK and SIC code, according to the filing?
Enlivex Ltd.'s CIK (Central Index Key) is 0001596812, and its SIC (Standard Industrial Classification) code is 2834, which corresponds to 'Pharmaceutical Preparations'.
Where is Enlivex Ltd.'s business address located?
Enlivex Ltd.'s business address is 37 DEREH MENACHEM BEGIN ST., 15TH FLOOR, TEL AVIV, Israel.
Filing Stats: 230 words · 1 min read · ~1 pages · Grade level 11.7 · Accepted 2026-03-26 08:32:01
Key Financial Figures
- $5 million — h of its AI agent-ready interface and a $5 million grant program to support developers and
Filing Documents
- ea028345301-6k_enlivex.htm (6-K) — 9KB
- ea028345301ex99-1_enlivex.htm (EX-99.1) — 11KB
- 0001213900-26-034383.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Enlivex Ltd. (Registrant) By: /s/ Oren Hershkovitz Name: Title: Oren Hershkovitz Chief Executive Officer Date: March 26, 2026 2